CoChat

Rapamycin‐insensitive mechanistic target of rapamycin regulates basal and resistance exercise‐induced muscle protein synthesis

Open access
Ogasawara, Riki, Suginohara, Takeshi · 2018 · The FASEB Journal
Cited by 67

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

We investigated whether rapamycin‐insensitive mechanistic target of rapamycin (mTOR) signaling plays a role in regulating resistance exercise‐induced muscle protein synthesis. We used a rodent model of resistance exercise and compared the effect of rapamycin, an allosteric mTOR inhibitor, with the effect of AZD8055, an ATP‐ competitive mTOR kinase inhibitor. The right gastrocnemius muscle of male Sprague‐Dawley rats age 11 wk was contracted isometrically via percutaneous electrical stimulation (100 Hz, 5 sets of ten 3‐s contractions, 7 s of rest between contractions, 3 min of rest between sets), and the left gastrocnemius muscle served as control. Vehicle, rapamycin, or AZD8055 were intraperitoneally injected 1 h before resistance exercise. Results indicated that both rapamycin and AZD8055 inhibited mTOR complex 1 (mTORC1)/70‐kDa ribosomal protein S6 kinase signaling similarly, whereas mTORC1/eukaryotic translation initiation factor 4E‐binding protein 1 signaling was greatly inhibited by AZD8055. Moreover, only AZD8055 inhibited the phosphorylation of Akt at Ser473, a downstream target of mTORC2. AZD8055, but not rapamycin, completely inhibited the resistance exercise‐induced increase in muscle protein synthesis. We conclude that the resistance exercise‐induced increase in muscle protein synthesis is an mTOR signaling‐dependent process. Furthermore, both rapamycin‐sensitive and ‐insensitive mTOR signaling reg ulate this event.—Ogasawara, R., Suginohara, T. Rapamycin‐insensitive mechanistic target of rapamycin regulates basal and resistance exercise‐induced muscle protein synthesis. FASEB J. 32, 5824–5834 (2018). www.fasebj.org

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.201701422r

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 19

  1. 10.1016/j.cell.2017.02.004 · DOI · Paper page
  2. 10.1016/j.molcel.2013.01.019 · DOI · Paper page
  3. 10.1113/jphysiol.2010.192856 · DOI · Paper page
  4. 10.1113/jphysiol.2003.047019 · DOI · Paper page
  5. 10.1038/srep31142 · DOI · Paper page
  6. Bodine S. C., 2001, Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat, Cell Biol., 3, 1014
  7. 10.1113/JP271365 · DOI · Paper page
  8. Kleinert M., 2014, Acute mTOR inhibition induces insulin resistance and alters substrate utilization in vivo. Mol, Metab., 3, 630, 10.1016/j.molmet.2014.06.004 · DOI · Paper page
  9. 10.1096/fj.10-168799 · DOI · Paper page
  10. 10.1371/journal.pone.0047258 · DOI · Paper page
  11. 10.1111/ajt.12799 · DOI
  12. 10.1152/ajpendo.00660.2011 · DOI · Paper page
  13. 10.1038/ncb2152 · DOI · Paper page
  14. 10.1073/pnas.0809136105 · DOI · Paper page
  15. 10.1016/j.molcel.2006.03.029 · DOI · Paper page
  16. 10.18632/oncotarget.3920 · DOI
  17. 10.1007/s00125-013-2861-9 · DOI
  18. 10.1016/j.celrep.2016.09.020 · DOI · Paper page
  19. 10.1016/j.molmet.2016.06.007 · DOI

Cited by

Metadata

Authors
Ogasawara, R., & Suginohara, T.
Venue
The FASEB Journal
Publisher
Wiley
Published
2018-05-14
Volume
32
Issue
11
Pages
5824-5834
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2804214951
Cited by
67
References
10
FWCI
4.21
Type
journal article
Language
en
Open access
bronze
Funders
Japan Society for the Promotion of Science London (26702028)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.